Clinical Trial Update: A Long-term Safety Study of Fluticasone Furoate (FF)/GW642444 in Japanese Subjects With COPD [Phase 3]

View source ↗

Summary

This completed Phase 3 long-term safety study evaluated the inhaled combination of fluticasone furoate and vilanterol (FF/GW642444) in Japanese patients with ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• BREO ELLIPTA (fluticasone furoate and vilanterol trifenatate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED | Results posted: 2013-08-12